Skip to main content

Find Clinical Trials

Home
Conditions
Myeloid Leukemia

Clinical trial condition

Myeloid Leukemia

Explore clinical trials studying Myeloid Leukemia. Study availability and eligibility vary by location and protocol.

26 public trials 5 recruiting studies

Refine in advanced search Browse all conditions

Myeloid Leukemia trial results

Completed

Safety, Tolerability, PK and Efficacy of AZD1152 in Patients With Relapsed Acute Myeloid Leukemia

NCT00497991

Conditions: Hematologic Diseases, Hemic and Lymphatic Diseases, Leukemia, +5 more
Locations: Research Site New York, United States

Research Site Houston, Texas, United States

Research Site Angers, France

Research Site Grenoble, France

View Trial Details

Completed

Trial Comparing Pegfilgrastim With Filgrastim as an Adjunct to Chemotherapy for Acute Myeloid Leukaemia (AML)

NCT00114764

Conditions: Agranulocytosis, Cytopenia, Hematologic Diseases, +10 more
Locations: Not specified

View Trial Details

Completed

HLA-Mismatched Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation for Hematological Malignancies

NCT00001748

Conditions: Bone Marrow Diseases, Chronic Disease, Disease Attributes, +25 more
Locations: National Heart, Lung and Blood Institute (NHLBI) Bethesda, Maryland, United States

View Trial Details

Active, Not Recruiting

A Phase I/II Study of Gilteritinib and Momelotinib for Patients With Relapsed or Refractory FLT3-Mutated Acute Myeloid Leukemia

NCT06235801

Conditions: Hematologic Diseases, Hemic and Lymphatic Diseases, Leukemia, +4 more
Locations: MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Active, Not Recruiting

Anti-Leukemia Immune Responses After Irradiation of Extramedullary Tumors

NCT05035706

Conditions: Acute Myeloid Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +7 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Active, Not Recruiting

Integrated Actionable Aging Assessment for Cancer Patients Pilot

NCT05871008

Conditions: Bladder Cancer, Blood Protein Disorders, Breast Cancer, +49 more
Locations: University of Colorado Hospital Aurora, Colorado, United States

View Trial Details